Praxis Precision Medicines (PRAX) Long-Term Investments (2024 - 2026)

Praxis Precision Medicines' Long-Term Investments history runs 3 years deep, the most recent figure standing at $660.9 million for Q1 2026.

• In Q1 2026, Long-Term Investments rose 358.88% year-over-year to $660.9 million; the TTM figure through Mar 2026 stood at $660.9 million (up 358.88% YoY), while the FY2025 annual figure was $326.8 million, up 324.57% from the prior year.
• Long-Term Investments for Q1 2026 stood at $660.9 million, up from $326.8 million in the prior quarter.
• The five-year high for Long-Term Investments was $660.9 million in Q1 2026, with the low at $35.9 million in Q1 2024.
• The 3-year median for Long-Term Investments is $122.0 million (2025), against an average of $183.1 million.
• The sharpest annual moves came in 2025 and 2026: Long-Term Investments jumped 77.38% in 2025, then soared 358.88% in 2026.
• Praxis Precision Medicines' Long-Term Investments stood at $77.0 million in 2024, then soared by 324.57% to $326.8 million in 2025, then jumped by 102.27% to $660.9 million in 2026.
• Business Quant data shows PRAX's Long-Term Investments at $660.9 million in Q1 2026, $326.8 million in Q4 2025, and $122.0 million in Q3 2025.